{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:48:18Z","timestamp":1772160498718,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T00:00:00Z","timestamp":1208908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    Recombinant factor VIIa (rFVIIa) is used for haemophilic patients with inhibitors against coagulation factor VIII or IX, but there is also an off\u2010label use of rFVIIa for patients with massive bleeding. The aim of the present study was to review the randomized clinical trials (RCT) for evidence of such an approach.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods\u2002<\/jats:bold>\n                    In October 2007, a review of RCT involving rFVIIa for non\u2010haemophilic indications was performed. The effect of rFVIIa on blood loss and transfusion requirements was recorded.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Seventeen RCTs were identified concerning different bleeding conditions, for example, secondary to surgery, infection and stem cell transplantation. Three pilot studies reported a significant reduction in transfusion requirements and\/or blood loss in the rFVIIa\u2010treated groups, but these have not been confirmed in large randomized trials. No difference in thromboembolic complications between rFVIIa and placebotreated patients were found, except for a study in patients with intracranial haemorrhage. In the intracranial haemorrhage study, 16 out of 16 arterial thrombotic events and 19 out of 21 combined arterial and venous thromboembolic events were found in the rFVIIa\u2010treated patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    There is little evidence to support routine use of rFVIIa for patients with massive bleeding based on the results of the randomized trials performed. In patients with a normal haemostatic system, administration of rFVIIa may be associated with an increased risk of thromboembolic events.\n                  <\/jats:p>","DOI":"10.1111\/j.1423-0410.2008.01063.x","type":"journal-article","created":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T02:49:22Z","timestamp":1209005362000},"page":"1-7","source":"Crossref","is-referenced-by-count":30,"title":["Off\u2010label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials"],"prefix":"10.1111","volume":"95","author":[{"given":"P. I.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5,11]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei169"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00678.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-002-1471-7"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199603000-00032"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199409000-00016"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/000313480206800702","article-title":"Blood transfusions correlate with infections in trauma patients in a dose\u2010dependent manner","volume":"68","author":"Claridge JA","year":"2002","journal-title":"Am Surg"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2004.07.006"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-3048"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5934"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TA.0000060261.10597.5C"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.12.1499"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05155-7"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-007-0240-2"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)90000-2"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01015.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.3.594"},{"key":"e_1_2_5_18_2","first-page":"S15","article-title":"Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma","volume":"49","author":"Martinowitz U","year":"2002","journal-title":"Can J Anaesth"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2006.09.001"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00824.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00393.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01523.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000149628.80251.b8"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042991"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000186837.78432.2f"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.015"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12268-4"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei102"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20470"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20458"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200502000-00006"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2005.10.019"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei244"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2006.08.010"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000233369.03358.c1"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181557d45"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TA.0000171453.37949.B7"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01203.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AACN.0000269257.06794.40"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5026"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e31804798a4"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc4975"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000046238.23903.FC"},{"key":"e_1_2_5_44_2","first-page":"324","article-title":"Predicting hemorrhage using preoperative coagulation screening assays","volume":"3","author":"Dzik WH","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200107000-00001"},{"key":"e_1_2_5_46_2","first-page":"34","article-title":"Thromboelastography in liver transplantation","volume":"4","author":"Kang Y","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199902000-00016"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199704000-00023"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4463256.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00759.x"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90245-3"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.11.001"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01160.x"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000159087.85970.38"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005011.pub2"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2008.01063.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2008.01063.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:33:22Z","timestamp":1696876402000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2008.01063.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1423-0410.2008.01063.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2008.01063.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1115296.571306","asserted-by":"object"}]},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,11]]}}}